agonistaheadaiaimsalreadyanalystannouncedantibodyapproachapprovalascoasgctashassetautoimmunebasedbehindbelievesbetterbiobiopharmabiosciencesbiotechbrainbreastbrianbuildingbuiltcambridgecancercatalystscellceochairmanclinicalcocombinationcompaniescompanyconditionsconferencecoverscurrentdatadaviddaydegradationdelivereddescribesdesigndesigneddevelopdevelopingdevelopmentdirectordiscoverydiscussesdiseasediseasesdmddrugearlierearlyeditingenvironmenteuropeexplainsfdafieldfirmfirstfocusedfounderfrontfundfuturegenegenerationglobalgoingheadhealthhealthcarehelphighlightsincludingindustryinhibitorinhibitorsinnovationinternationalinvestorjefferiesjohnjoneskeykidneylastlatelatestlaunchlaunchedleadlifelondonmedicinemedicinesmillionmoleculemonthmrnamultiplenextnovelobesityoncologyoraloxfordparetopartnerpatientspaulpharmaphasepipelinepivotalplatformpluspossiblepresentedpreviewsprogramprogramsproteinraiseraisedrbcreadreadoutrecentrecentlyreceptorresearchrnascheduledsciencesciencesscotlandsectorsecuritiesseniorseriessfsharesshowingsmallspacestagestatestifelstudysummitswisssyndrometaketalkstargettargetingtechnologytellstherapeuticstherapiestherapythoughtsthreetodaytourtreatmenttrialtrialstumortypeukuniqueuniversityupcomingupdateupdatesususeusesusingvaccineviawalksweekwillworkworkingyear